Search Ontology:
ChEBI
beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer
- Term ID
- CHEBI:140691
- Synonyms
-
- a globoside GalGb4Cer
- beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-galactopyranosyl-(1->3)-alpha-D-galactopyranosyl-(1->4)-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranosyl-(1<->1')-ceramide
- beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-Cer
- beta-D-Galp-(1->3)-beta-D-GalpNAc-(1->3)-alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-beta-D-Glcp-(1<->1')-Cer
- Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer
- Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta1-1Cer
- Galbeta1->3GalNAcbeta1->3Galalpha1->4Galbeta1->4Glcbeta1->1Cer
- GalGbOse4Cer
- GL-X
- SSEA-3 antigen
- SSEA-3a
- SSEA3
- stage-specific embryonic antigen 3
- stage-specific embryonic antigen-3
- Definition
- A glycopentaosylceramide having β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→3)-α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl as the glycopentaosyl component. It is a glycosphingolipid that has previously been used to identify cells with stem cell-like, multipotent, and pluripotent characteristics.
- References
-
- lipidmaps:LMSP0502AE00
- pubmed:10837462
- pubmed:16643871
- pubmed:18685093
- pubmed:2146256
- pubmed:23175153
- pubmed:23441574
- pubmed:23514702
- pubmed:23668861
- pubmed:25561682
- pubmed:26677875
- pubmed:2885313
- pubmed:30271856
- pubmed:30997834
- pubmed:31817926
- pubmed:31936807
- pubmed:32525407
- pubmed:32684574
- pubmed:6143701
- pubmed:6863318
- pubmed:7595524
- pubmed:7983056
- wikipedia.en:Stage_specific_embryonic_antigen_3
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer
Phenotype where environments contain beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer
Phenotype modified by environments containing beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer
Phenotype affecting beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer
Human Disease Model